Similarly, the use of A-971432, a selective S1PR5 agonist, preserves BBB integrity and activates pro-survival pathways, such as brain-derived neurotrophic factor (BDNF), Akt, and ERK, in an animal model of Huntington’s disease [211]. This evidence concerns the gene BDNF and juvenile Huntington disease.